2019. EFFICACY OF NIVOLUMAB (NWO) DURING 2+ LINE TREATMENT AND QUALITY OF LIFE IN PATIENTS WITH ADVANCED REFRACTORY NON-SMALL CELL LUNG CANCER: INTERIM RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY. Voprosy onkologii. 65, 1 (Jan. 2019), 99–105. DOI:https://doi.org/10.37469/0507-3758-2019-65-1-99-105.